Pub. Date : 1999 Feb
PMID : 9973252
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Increased STAT5b DNA-binding activity was observed in cells treated with the proteasome inhibitor MG132, suggesting that at least one component of the GH receptor (GHR)-JAK2-STAT5b signaling pathway becomes labile in response to continuous GH treatment. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | signal transducer and activator of transcription 5B | Rattus norvegicus |
| 2 | Increased STAT5b DNA-binding activity was observed in cells treated with the proteasome inhibitor MG132, suggesting that at least one component of the GH receptor (GHR)-JAK2-STAT5b signaling pathway becomes labile in response to continuous GH treatment. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | growth hormone receptor | Rattus norvegicus |
| 3 | Increased STAT5b DNA-binding activity was observed in cells treated with the proteasome inhibitor MG132, suggesting that at least one component of the GH receptor (GHR)-JAK2-STAT5b signaling pathway becomes labile in response to continuous GH treatment. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | growth hormone receptor | Rattus norvegicus |
| 4 | Increased STAT5b DNA-binding activity was observed in cells treated with the proteasome inhibitor MG132, suggesting that at least one component of the GH receptor (GHR)-JAK2-STAT5b signaling pathway becomes labile in response to continuous GH treatment. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | Janus kinase 2 | Rattus norvegicus |
| 5 | Increased STAT5b DNA-binding activity was observed in cells treated with the proteasome inhibitor MG132, suggesting that at least one component of the GH receptor (GHR)-JAK2-STAT5b signaling pathway becomes labile in response to continuous GH treatment. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | signal transducer and activator of transcription 5B | Rattus norvegicus |